Proshares Trust ZBIO
ZBIO
$28.94 +0.76 (+2.71%)
As of: Oct 21, 2026 · 9:36 AM EDT

Zenas BioPharma (ZBIO) Non-Current Debt (2025 - 2026)

Updated

Zenas BioPharma (ZBIO) posted Non-Current Debt of $222.96 million for Q2 2026, up 15.1% from the prior quarter.

Analysis

Zenas BioPharma (ZBIO) Non-Current Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Zenas BioPharma's Non-Current Debt came in at $78.64 million.

  • According to Business Quant data, Non-Current Debt for the three prior quarters was $193.63 million (Q1 2026), $78.64 million (Q4 2025) and $72.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,134.42 Bn 1,103.01 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.36 Bn 537.89 Bn 17.26 Bn 37.34 Bn
3 AbbVie 510.11 Bn 483.22 Bn 12.70 Bn 62.48 Bn
4 Merck 365.37 Bn 319.75 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.64 Bn 261.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 262.52 Bn 236.21 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.62 Bn 192.02 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 192.60 Bn 166.80 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn 60.50 Bn
10 Zenas BioPharma 1.83 Bn 1.15 Bn - 297.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 297.02 Mn
Mar 31, 2026 265.72 Mn
Dec 31, 2025 78.64 Mn
Sep 30, 2025 72.99 Mn
API Access

Zenas BioPharma Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ZBIO&period=max&api_key=YOUR_API_KEY